Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial (Q37251132)
Jump to navigation
Jump to search
scientific article published on 25 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial |
scientific article published on 25 June 2013 |
Statements
1 reference
Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial (English)
1 reference
Johnny Ludvigsson
1 reference
Kevan C Herold
1 reference
William Hagopian
1 reference
Nicole Sherry
1 reference
David Carlin
1 reference
Ezio Bonvini
1 reference
Syd Johnson
1 reference
Kathryn E Stein
1 reference
Scott Koenig
1 reference
Anastasia G Daifotis
1 reference
Protégé Trial Investigators
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference